GNFTF - Breaking Down The NASH Cirrhosis Market - Gilead Poised For Success But Is It Enough To Boost Stock Price?
In my most recent article, I provided a segmentation of the overall NASH market (between fibrosis and cirrhosis) and briefly discussed each of the major players in the NASH fibrosis market. Now, I'd like to discuss the NASH cirrhosis market and provide an overview of the firms operating in the space.
Segmenting the Overall NASH Market
To start, I'd like to provide my segmentation of the NASH market; since this article focuses on NASH cirrhosis, we need to know the approximate percentage of the overall NASH market that cirrhosis represents. Though the following section